Vantiva’s Cobra 5G Router Earns T-Mobile Certification, Expanding 5G Access for MVNO Ecosystems
Built with proprietary technologies, the solution delivers reliable connectivity and operational efficiency across North America
Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, today announced that T-Mobile has officially certified Vantiva’s Cobra 5G Fixed Wireless Access (FWA) router for deployment within its Mobile Virtual Network Operator (MVNO) ecosystem. This certification expands opportunities for T-Mobile MVNOs to access advanced 5G FWA technology.
With this certification, MVNOs operating on T-Mobile’s network, the largest 5G network in America, can now offer the Cobra 5G router directly to their clients.
Vantiva’s Cobra 5G delivers high-performance connectivity with features specifically designed to meet businesses' operational needs. Key features of the product and ecosystem include:
- WAN Sensing™ to ensure uninterrupted connectivity with seamless network switching from a primary to backup connection
- Indoor5G™ and RuralBoost™ technologies to enable Cobra 5G to extend the FWA service area by up to 40% via proven proprietary technologies
- NaviGate Companion™ mobile application for end user local configuration and management
- ECO Control™ cloud-based device management platform for remote FoTA and support
“Receiving T-Mobile certification for the Cobra 5G strengthens our ability to support MVNO partners by giving them a high-quality, business-focused FWA solution to offer their customers," said Roberto Salermo, SVP of Business Development at Vantiva. "For MVNOs, this means access to reliable, high-speed connectivity with advanced network management tools that help them operate more efficiently and scale with confidence."
With this certification, Vantiva continues to demonstrate the agility and expertise of an industry-leading innovator, delivering solutions that set new standards for performance and reliability.
About Vantiva
Pushing the Edge
Vantiva (Euronext Paris: VANTI) is a global technology leader in the Customer Premises Equipment (CPE) market. For over 130 years, Vantiva (formerly known as Technicolor) has delivered solutions that connect what matters most. Today, the company continues to redefine connectivity with industry-leading broadband, video, and IoT-driven smart systems that elevate how people live, work, and connect globally.
Vantiva combines a customer-focused approach with decades of software development, electronics hardware design, and flexible supply chain expertise to deliver high-quality solutions at scale. This proficiency has positioned Vantiva as a trusted provider to leading network service providers, enterprise customers, and consumers around the world.
A strong commitment to sustainability and responsible business practices has earned Vantiva multiple Gold and Platinum Medals from EcoVadis for environmental and social performance. These awards place the company among the top 2% of organizations in its category evaluated globally.
With its headquarters in Paris and major offices in Australia, Brazil, China, India, South Korea, the United Kingdom, and the United States, the company serves a diverse global customer base.
For more information, please visit vantiva.com and follow Vantiva on LinkedIn and X (Twitter).
View source version on businesswire.com: https://www.businesswire.com/news/home/20250922893344/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 202522.9.2025 20:30:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present new data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting. The data, which will be presented in a late-breaking oral presentation on Sunday, October 19, 2025, focuses on trial participants who were previously treated with a PARP inhibitor, a patient population with particularly poor prognosis. The ROSELLA trial is being conducted in collaboration with The GOG Foundation, Inc. (GOG-F), the European Network of Gynaecological Oncological Trial groups (ENGOT), the Asia-Pacific Gynecologic Oncology Trials Group (APGOT), the Latin American Cooperative Oncology Group (LACOG) a
Arada Enters UK with Acquisition of British Developer Regal, Committing AED2.5 Billion to Accelerate London Residential Development22.9.2025 16:31:00 CEST | Press release
Developer’s UK arm, to be renamed Arada London, has 10,000-unit pipeline over 11 projects Arada has announced its expansion into the UK housing market through the acquisition of a 75% stake in Regal, one of London’s leading residential-led mixed-use developers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922005640/en/ Arada enters UK with acquisition of British developer Regal, committing AED2.5 billion to accelerate London residential development (Photo: AETOSWire) This marks Arada’s entry into the UK and second international expansion, aligning with its strategy of growing and diversifying its business geographically. Having already established a strong presence in the UAE since its launch in 2017 and expanded into Australia in 2024, the acquisition of Regal gives Arada an immediate presence in the London market and platform on which to deliver at speed and scale. As part of the transaction, Arada is also committing
Onego Bio Receives FDA “No Questions” Letter on GRAS Status of Bioalbumen®22.9.2025 16:00:00 CEST | Press release
Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced today that the U.S. Food and Drug Administration (FDA) has issued a “no questions” letter regarding the company’s conclusion that its flagship product, marketed as Bioalbumen®, is Generally Recognized As Safe (GRAS) under its conditions of use in a wide range of food and beverage applications. The FDA’s decision, communicated in response to GRAS Notice No. GRN 1249, confirms that Bioalbumen®—a highly functional ovalbumin protein with an amino acid sequence identical to that found in chicken eggs—can be used as a source of dietary protein and, for example, as a foaming, gelling, and binding agent in baked goods, beverages, meat analogs, confections, sauces, and more. Produced via precision fermentation with the filamentous fungus Trichoderma reesei, Bioalbumen® delivers high-quality nutrition and matches the functionality of traditional egg protein. It is designed to diversify egg protei
Boomi Appoints Keyur Ajmera as Chief Information Officer22.9.2025 15:00:00 CEST | Press release
Veteran technology leader to drive Boomi’s global IT strategy and accelerate innovation at scale Boomi™, the leader in AI-driven automation, today announced the appointment of Keyur Ajmera as Chief Information Officer, responsible for driving Boomi’s global IT strategy, enterprise systems, cybersecurity, and digital operations. Ajmera will focus on scaling technology to support Boomi’s rapid growth, strengthening the company’s IT foundation for AI adoption, and ensuring operational excellence as Boomi accelerates its agentic transformation journey. He will report to President of Global Operations and Chief Financial Officer, Val Rainey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922974855/en/ Boomi Appoints Keyur Ajmera as Chief Information Officer Ajmera, who most recently served as Senior Vice President of Technology Operations and Innovation at Towne Park and previously as the first CIO of iCIMS, brings more than t
LR Health & Beauty Takes Fragrance Segment to a New Level and Launches Two New Collections22.9.2025 14:42:00 CEST | Press release
Social commerce company is setting new trends to mark its 40th anniversary and the anniversary of its perfume range Choosing a favourite perfume is a highly personal decision for many people. Because a fragrance is more than just a scent. It expresses your style, your attitude to life and stirs up emotions – in yourself and in the people around you. Since its foundation in 1985, LR Health & Beauty has been aware of the importance and potential of a successful fragrance range. This is because one of the key advantages of direct sales is the personal advice provided to customers by independent LR sales partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922789464/en/ LR sets new standards in the fragrance sector with the launch of two new fragrance collections "LR has continuously developed the fragrance portfolio based on direct feedback from our sales partners, our wealth of experience and the latest scientific findi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom